Stocks Rally Before Market Open with Key Moves from Alphabet, Option Care Health, and More
- Alphabet shares up 0.5% following a significant power agreement with Constellation Energy.
- Option Care Health’s stock surged over 20% amid acquisition talks with McKesson.
- Corteva and Procter & Gamble stocks rose after analyst upgrades, indicating strong upside potential.
Pre-market trading saw notable movements in several stocks, most prominently triggered by corporate announcements and changes in analyst ratings. Constellation Energy shares experienced a remarkable increase of more than 6%, while Alphabet’s stock rose approximately 0.5%, following the announcement of a major long-term power agreement. This agreement involves Google purchasing power associated with 890 megawatts of new nuclear capacity as well as a separate agreement for 2,700 megawatts, supporting over $4.3 billion in investments by Constellation.
Shares of Option Care Health surged more than 20% after a Financial Times report indicated that McKesson and private equity firm Clayton Dubilier & Rice are in advanced discussions to acquire the infusion services provider for more than $5 billion. McKesson’s stock also saw an increase, rising by 1.5% in the wake of this news.
In a regulatory filing, Berkshire Hathaway revealed it has acquired around 2.4 million shares of Lennar, which pushed Lennar’s stock up by 1.5%. Meanwhile, Berkshire’s shares experienced a modest gain.
NeoGenomics shares rose by 5% following the announcement of a succession plan that will see current President and COO Warren Stone succeed Tony Cook as CEO in January 2027. The company also disclosed preliminary third-quarter revenues of $209 million, surpassing the consensus estimate of $205.9 million, according to FactSet.
Advanced Micro Devices (AMD) stock climbed nearly 2% after Citi raised its price target to $800, suggesting more than a 26% upside from Monday’s closing price. The bank noted increased demand for CPUs, driven in part by Meta’s Muse AI agent, stating, “AMD will be the primary beneficiary of the CPU renaissance.”
Procter & Gamble’s shares gained 1.2% after Evercore ISI upgraded the stock to outperform from in line and increased its price target to $166, implying about 14% upside potential. Additionally, Corteva shares rose nearly 3% following an upgrade by JPMorgan to overweight from neutral, with a price target of $19 that suggests a 53% upside from Monday’s closing price. Analysts attributed this to Corteva’s enhanced focus on crop chemicals and improving agricultural commodity prices.
News Courtesy of CNBC
